Division of Cardiology, Mount Sinai School of Medicine, New York, NY.
Circ Cardiovasc Interv. 2013 Oct 1;6(5):507-17. doi: 10.1161/CIRCINTERVENTIONS.112.000248. Epub 2013 Sep 24.
Re-endothelialization is delayed after drug-eluting stent (DES) implantation. In this setting, neointima is more prone to become lipid laden and develop neoatherosclerosis (NA), potentially increasing plaque vulnerability.
Optical coherence tomography and near-infrared spectroscopy with intravascular ultrasound were used to characterize NA in 65 (51 DES and 14 bare-metal stents) consecutive symptomatic patients with in-stent restenosis. Median duration poststent implantation was 33 months. Optical coherence tomography-verified NA was observed in 40 stents with in-stent restenosis (62%), was more prevalent in DES than bare-metal stents (68% versus 36%; P=0.02), and demonstrated significantly higher prevalence of thin-cap neoatheroma (47% versus 7%; P=0.01) in DES. Near-infrared spectroscopy assessment demonstrated that the total lipid core burden index (34 [interquartile range, 12-92] versus 9 [interquartile range, 0-32]; P<0.001) and the density of lipid core burden index (lipid core burden index/4 mm, 144 [interquartile range, 60-285] versus 26 [interquartile range, 0-86]; P<0.001) were higher in DES compared with bare-metal stents. Topographically, NA was classified as I (thin-cap NA), II (thick-cap NA), and III (peri-strut NA). Type I thin-cap neoatheroma was more common in DES (20% versus 3%; P=0.01) and in areas of the stented segment without significant in-stent restenosis (71%). Periprocedural myocardial infarction occurred only in DES (11 versus 0; P=0.05), of which 6 (55%) could be attributed to segments with >70% in-stent restenosis. By logistic regression, prior DES was the only independent predictor of both NA (odds ratio, 7.0; 95% confidence interval, 1.7-27; P=0.006) and periprocedural myocardial infarction (odds ratio, 1.8; 95% confidence interval, 1.1-2.4; P=0.05).
In-stent thin-cap neoatheroma is more prevalent, is distributed more diffusely across the stented segment, and is associated with increased periprocedural myocardial infarction in DES compared with bare-metal stents. These findings support NA as a mechanism for late DES failure.
药物洗脱支架(DES)植入后再内皮化延迟。在这种情况下,新生内膜更容易富含脂质并发展为新生动脉粥样硬化(NA),从而潜在地增加斑块的脆弱性。
使用光学相干断层扫描和血管内超声对 65 例(51 例 DES 和 14 例裸金属支架)连续症状性支架内再狭窄患者的 NA 进行特征描述。支架植入后中位时间为 33 个月。在 40 个支架内再狭窄(62%)中观察到光学相干断层扫描证实的 NA,DES 中 NA 的发生率高于裸金属支架(68%对 36%;P=0.02),DES 中薄帽新生动脉粥样硬化的发生率明显更高(47%对 7%;P=0.01)。近红外光谱评估显示,总脂质核心负荷指数(34 [四分位间距,12-92] 对 9 [四分位间距,0-32];P<0.001)和脂质核心负荷指数密度(脂质核心负荷指数/4mm,144 [四分位间距,60-285] 对 26 [四分位间距,0-86];P<0.001)在 DES 中均高于裸金属支架。从拓扑学角度来看,NA 分为 I 型(薄帽新生动脉粥样硬化)、II 型(厚帽新生动脉粥样硬化)和 III 型(支架内新生动脉粥样硬化)。DES 中更常见 I 型(薄帽新生动脉粥样硬化)(20%对 3%;P=0.01)和支架段无明显支架内再狭窄的区域(71%)。仅 DES 术中发生心肌梗死(11 例对 0 例;P=0.05),其中 6 例(55%)可归因于>70%的支架内再狭窄节段。通过逻辑回归,DES 是 NA(优势比,7.0;95%置信区间,1.7-27;P=0.006)和围手术期心肌梗死(优势比,1.8;95%置信区间,1.1-2.4;P=0.05)唯一的独立预测因素。
DES 中支架内薄帽新生动脉粥样硬化更为普遍,在支架段内分布更为弥散,与裸金属支架相比,围手术期心肌梗死的发生率更高。这些发现支持 NA 是 DES 晚期失败的机制。